TIDMGSK

RNS Number : 5967Z

GlaxoSmithKline PLC

13 January 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             18 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             60 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             13 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications and CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             54 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                   Mr D Jackson 
====  ======================================  ===================================================== 
 b)    Position/status                        PCA of Ms S Jackson (SVP, Global Communications 
                                               and CEO Office) 
====  ======================================  ===================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ===================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ===================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ===================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ===================== 
   GBP17.9284                                                               19 
   =======================================================================  ===================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ====================================================================  ============================ 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ===================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr L Miels 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             4 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr D Redfern 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             67 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Simard 
====  ======================================  ================================================= 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             19 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P C Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             39 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Waterhouse 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer of ViiV Healthcare 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             53 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms V A Whyte 
====  ======================================  ================================================= 
 b)    Position/status                        Company Secretary 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.9284                                                             49 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-09 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBXLFFBFLXBBF

(END) Dow Jones Newswires

January 13, 2020 05:34 ET (10:34 GMT)

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Dic 2020 a Gen 2021 Clicca qui per i Grafici di Glaxosmithkline
Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Gen 2020 a Gen 2021 Clicca qui per i Grafici di Glaxosmithkline